Back

Integrating spatial and single-cell multi-omics analysis of induced pluripotent stem cell-derived cervical adenocarcinoma model

Kamata, S.; Taguchi, A.; Iuchi, H.; Ikeda, Y.; Maruyama, R.; Nakanishi, Y.; Sugi, T.; Okuma, Y.; Kobayashi, O.; Tomita, N.; Yoshimoto, D.; Wang, L.; Moritsugu, N.; Takahashi, C.; Tagami, M.; Matsunaga, H.; Okayama, T.; Manabe, R.-i.; Kiyotani, K.; Ikeo, K.; Okazaki, Y.; Kiyono, T.; Masuda, S.; Hamada, M.; Takeyama, H.; Kawana, K.

2026-05-06 cancer biology
10.64898/2026.05.01.722143 bioRxiv
Show abstract

Human papillomavirus 18 (HPV18) preferentially infects cervical stem cell-like cells and is strongly associated with adenocarcinoma. However, the mechanisms underlying differentiation into cervical adenocarcinoma remain unclear due to the lack of appropriate experimental models. We aimed to establish a model of HPV18-associated cervical adenocarcinoma and elucidate its molecular and cellular differentiation mechanisms. HPV18 E6/E7 were introduced into induced pluripotent stem cell-derived reserve cell-like cells (iRCs) to generate tumor models. Spatial transcriptomics and single-cell multi-omics analyses were performed to integrate histological and molecular data. A distinct component (Gland_A) exhibited morphological and immunohistochemical features of cervical adenocarcinoma and was efficiently induced in iRC-18 tumors. Gland_A showed increased chromatin accessibility and elevated expression of FOXA1, FOXA2, and ALDH1A1. Analysis of clinical samples confirmed enrichment of ALDH1A1 in HPV-associated adenocarcinomas. This model recapitulates key features of HPV18-associated cervical adenocarcinoma and provides insights into its differentiation mechanisms.

Matching journals

The top 16 journals account for 50% of the predicted probability mass.

1
Advanced Science
249 papers in training set
Top 3%
6.4%
2
Nature Communications
4913 papers in training set
Top 33%
4.8%
3
eLife
5422 papers in training set
Top 22%
4.0%
4
Signal Transduction and Targeted Therapy
29 papers in training set
Top 0.3%
3.7%
5
Scientific Reports
3102 papers in training set
Top 34%
3.7%
6
The Innovation
12 papers in training set
Top 0.1%
3.6%
7
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 2%
3.6%
8
Frontiers in Oncology
95 papers in training set
Top 1%
3.6%
9
PLOS ONE
4510 papers in training set
Top 43%
2.9%
10
iScience
1063 papers in training set
Top 8%
2.6%
11
Cell Discovery
54 papers in training set
Top 2%
2.4%
12
Journal of Translational Medicine
46 papers in training set
Top 0.5%
2.1%
13
Acta Biochimica et Biophysica Sinica
19 papers in training set
Top 0.2%
2.1%
14
Cell Reports
1338 papers in training set
Top 22%
1.9%
15
Molecular Cancer
14 papers in training set
Top 0.3%
1.8%
16
Journal of Genetics and Genomics
36 papers in training set
Top 0.9%
1.7%
50% of probability mass above
17
Protein & Cell
25 papers in training set
Top 1%
1.7%
18
International Journal of Cancer
42 papers in training set
Top 0.7%
1.7%
19
Cell Reports Medicine
140 papers in training set
Top 4%
1.5%
20
Gastroenterology
40 papers in training set
Top 1%
1.5%
21
Communications Biology
886 papers in training set
Top 11%
1.5%
22
Clinical and Translational Medicine
30 papers in training set
Top 0.4%
1.5%
23
Oncogene
76 papers in training set
Top 1%
1.5%
24
Genome Medicine
154 papers in training set
Top 6%
1.2%
25
Cell Death Discovery
51 papers in training set
Top 0.8%
1.2%
26
Science China Life Sciences
26 papers in training set
Top 1%
1.2%
27
Cancer Research
116 papers in training set
Top 3%
1.2%
28
British Journal of Cancer
42 papers in training set
Top 1%
0.9%
29
Cancer Letters
32 papers in training set
Top 0.5%
0.9%
30
Cancers
200 papers in training set
Top 4%
0.9%